Abstract

Mastitis, inflammation of the bovine mammary gland, is generally caused by intramammary infection with bacteria, and antimicrobials have long been a corner stone of mastitis control. As societal concern about antimicrobial use in animal agriculture grows, there is pressure to reduce antimicrobial use in dairy farming. Point-of-care tests for on-farm use are increasingly available as tools to support this. In this Research Reflection, we consider available culture-dependent and culture-independent tests in the context of ASSURED criteria for low-resource settings, including convenience criteria, scientific criteria and societal criteria that can be used to evaluate test performance. As tests become more sophisticated and sensitive, we may be generating more data than we need. Special attention is given to the relationship between test outcomes and treatment decisions, including issues of diagnostic refinement, antimicrobial susceptibility testing, and detection of viable organisms. In addition, we explore the role of technology, big data and people in improved performance and uptake of point-of-care tests, recognising that societal barriers may limit uptake of available or future tests. Finally, we propose that the 3Rs of reduction, refinement and replacement, which have been used in an animal welfare context for many years, could be applied to antimicrobial use for mastitis control on dairy farms.

Highlights

  • Setting the scene: background and aim Mastitis is an inflammation of the mammary gland, frequently caused by intramammary infections (IMI), and occasionally by mechanical or chemical trauma, or when cleaning liquids are mistaken for teat disinfectants

  • Mastitis treatment is based on knowledge of severity, causative agent and prognosis so that anti-inflammatory, antimicrobial and supportive treatments can be selected for maximum efficacy and minimal side effects, which include potential selection for antimicrobial resistance (AMR)

  • The contribution of antimicrobial use (AMU) to selection for AMR has become of concern due to actual or predicted adverse effects in human and veterinary health (O’Neill, 2016)

Read more

Summary

Research Reflection

Cite this article: Malcata FB, Pepler PT, O’Reilly EL, Brady N, Eckersall PD, Zadoks RN and Viora L (2020). Point-of-care tests for bovine clinical mastitis: what do we have and what do we need? Journal of Dairy Research 87 (S1), 60–66. Received: 30 October 2019 Revised: 15 February 2020 Accepted: 21 February 2020 First published online: 30 July 2020.

What do we need?
Convenience criteria
Scientific criteria
Level of differentiation
Societal criteria
What do we have?
Culture independent pathogen information
Future developments
Harnessing the power of technology
Harnessing the power of data
Harnessing the power of people
Findings
Final thoughts
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call